Topic Hub
35 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 35 of 35 clinical reviews.
Complete clinical guide to sermorelin acetate dosing in adolescents aged 12 to 17, covering weight-based protocols, growth velocity monitoring, safety data, and titration strategies.
Read clinical reviewA physician-reviewed guide to monitoring sermorelin acetate in adolescents aged 12, 17, covering IGF-1 targets, growth velocity, bone age, safety labs, and dosing checkpoints.
Read clinical reviewEvidence-based sermorelin acetate dosing for adults aged 30, 49, including starting doses, titration schedules, injection technique, monitoring, and safety considerations reviewed by HealthRX physicians.
Read clinical reviewCompare sermorelin acetate pricing against tesamorelin, CJC-1295, ipamorelin, and recombinant hGH. Includes per-month costs, clinical evidence, and guidance on choosing the right GH secretagogue.
Read clinical reviewEvidence-based sermorelin acetate dosing for adults ages 50 to 64, including starting doses, titration schedules, monitoring protocols, and how perimenopause, andropause, and polypharmacy affect prescribing decisions.
Read clinical reviewA clinician-reviewed guide to sermorelin acetate dosing for adults ages 18 to 29, covering starting doses, titration schedules, injection technique, monitoring labs, and safety considerations specific to this age group.
Read clinical reviewEvidence-based guide to sermorelin acetate dosing for patients with liver disease, including pharmacokinetic considerations, monitoring protocols, and clinical recommendations for hepatic impairment.
Read clinical reviewEvidence-based guide to sermorelin acetate dosing adjustments in patients with chronic kidney disease, including pharmacokinetic considerations, monitoring protocols, and clinical recommendations.
Read clinical reviewEvidence-based review of sermorelin acetate safety during pregnancy and breastfeeding, including mechanism of action, animal data, FDA pregnancy category, and clinical recommendations.
Read clinical reviewA clinical review of sermorelin acetate's future formulations, pipeline developments, oral and sustained-release delivery systems, and how next-generation GHRH analogs may reshape growth hormone therapy.
Read clinical reviewEvidence-based guide to sermorelin acetate dosing in adults 65 and older, covering starting doses, titration, renal considerations, monitoring, and deprescribing.
Read clinical reviewHow to safely monitor sermorelin acetate in patients aged 65 and older. Covers IGF-1 targets, renal adjustments, fall risk, drug interactions, and deprescribing thresholds with primary-source citations.
Read clinical reviewEvidence-based guide to sermorelin acetate use in transplant recipients, people living with HIV, older adults, and patients with renal or hepatic impairment. Includes dosing considerations, safety signals, and clinical monitoring protocols.
Read clinical reviewA clinical deep dive into sermorelin acetate manufacturing, its FDA history, 503A compounding supply chain, and the shortage events that shaped patient access from 1997 to today.
Read clinical reviewA physician-level explanation of how sermorelin acetate activates the GHRH receptor, triggers the cAMP-PKA cascade in pituitary somatotrophs, and produces pulsatile growth hormone release through the GH-IGF-1 axis.
Read clinical reviewEvidence-based guidance on what to do when you miss a sermorelin acetate injection, how timing affects GH pulsatility, and when to resume your normal schedule.
Read clinical reviewEvidence-based monitoring protocol for sermorelin acetate in adults aged 30 to 49, covering IGF-1 targets, lab timing, safety markers, and when to adjust therapy.
Read clinical reviewEvidence-based monitoring guide for sermorelin acetate in adults aged 50 to 64. Covers IGF-1 tracking, cardiovascular screening, glucose surveillance, and dose adjustment protocols for this age group.
Read clinical reviewA clinician-grade review of sermorelin acetate off-label uses, including anti-aging, body composition, sleep quality, and cognitive support, with evidence ratings for each.
Read clinical reviewA clinical review of sermorelin acetate's patent history, FDA approval and withdrawal, current 503A compounding status, and what the generic pipeline looks like through 2026 and beyond.
Read clinical reviewA physician-reviewed guide to sermorelin acetate monitoring in children under 12 with growth hormone deficiency, covering dosing, lab schedules, safety signals, and FDA labeling requirements.
Read clinical reviewA physician-reviewed guide to sermorelin acetate dosing in children under 12, covering weight-based calculations, injection timing, growth monitoring, and FDA regulatory context for pediatric GHD.
Read clinical reviewEvidence-based review of sermorelin acetate safety in pediatric patients under 12, including FDA labeling history, weight-based dosing, adverse effects, and growth monitoring protocols.
Read clinical reviewA physician-level review of sermorelin acetate pharmacokinetics covering absorption after subcutaneous injection, plasma distribution, DPP-IV-mediated metabolism, and rapid renal elimination, with PubMed-cited evidence.
Read clinical reviewA clinical review of sermorelin acetate real-world evidence from registries, observational cohorts, and post-market data, including mechanism of action, efficacy signals, and gaps in the literature.
Read clinical reviewA clinician-grade review of sermorelin acetate's regulatory standing in the United States, European Union, Canada, and United Kingdom, including FDA history, 503A compounding rules, and global prescribing frameworks.
Read clinical reviewA clinician-reviewed guide to sermorelin acetate safety in adolescents aged 12, 17, covering growth-hormone physiology, clinical trial evidence, side-effect profiles, contraindications, and monitoring protocols.
Read clinical reviewA clinical deep-dive into sermorelin acetate safety for geriatric patients (65+), covering renal function, falls risk, drug interactions, IGF-1 monitoring, and prescribing considerations backed by primary sources.
Read clinical reviewA clinically grounded review of sermorelin acetate safety for adults aged 50, 64, covering cardiovascular risk, polypharmacy interactions, dosing, monitoring, and guideline context.
Read clinical reviewA clinician-reviewed guide to sermorelin acetate safety for adults aged 18, 29, covering pharmacology, side-effect profiles, fertility considerations, dosing, and monitoring protocols.
Read clinical reviewLearn the correct sermorelin acetate self-injection technique, including reconstitution, dosing, injection-site rotation, and storage. Reviewed by the HealthRX medical team.
Read clinical reviewHow to store sermorelin acetate correctly, protect peptide stability, and maximize shelf life. Includes reconstitution guidelines, temperature data, and clinical storage protocols.
Read clinical reviewEvidence-based guide to switching between sermorelin acetate and other growth hormone secretagogues or recombinant GH, including washout periods, dose bridging, and monitoring benchmarks.
Read clinical reviewA complete clinical guide to sermorelin acetate monitoring in young adults aged 18, 29, covering lab panels, dosing checkpoints, fertility considerations, and safety endpoints backed by primary evidence.
Read clinical reviewEvidence-based guide to discontinuing sermorelin acetate safely, including taper protocols, monitoring benchmarks, and what to expect after stopping GHRH therapy.
Read clinical review